Molecular biomarkers, including Ki-67 proliferation index, NF2 gene status, TERT promoter mutations, and H3K27me3, which are pivotal for tumor classification and prognosis have been the subject of study of recent radiomic studies [9, 17, 31]. The gene discussed is MKI67; the disease is neoplasm.